Quantifying the Cost of Measles Outbreak in the U.S. and How Costs Scale with Outbreak Size
Sriudomporn, S.; Patenaude, B. N.
10.1101/2025.10.24.25338724 medRxivShow abstract
ImportanceIn 2025, the United States experienced the largest number of measles cases since its elimination in 2000. These outbreaks require extensive public health responses to mitigate, consume substantial hospital resources, and impose an economic and financial burden on state and federal budgets. ObjectiveTo review evidence on the costs of measles outbreaks in the United States between 2000 and 2025, as well as to examine how costs scale with outbreak size to better model the costs associated with measles outbreaks. Evidence ReviewWe conducted a literature review using PubMed to identify studies published between January 1, 2000, and October 7, 2025, using terms related to measles cases, costs, and outbreak response, across all 50 states in the United States of America. Additional publicly available reports beyond the PubMed published literature were identified through a review of official CDC and state health department reports. FindingsA total of 120 articles were screened, 33 underwent full text review, and data were extracted from 19 articles, yielding outbreak relevant costs in 18 different states. Eight additional reports in the gray literature were identified. Outbreak size ranged from 1 to 802 cases. Average outbreak cost per case was estimated at $43,203.65, while the average cost per contact was $443.46. Average cost per case varied from $33,415.75 from the medical provider perspective to $58,591.50 when including public health response costs. The incremental cost per case was estimated at $16,197.13 per additional measles case, after accounting for the fixed costs of initiating a public health response. Conclusion and RelevanceMeasles outbreaks in the U.S. continue to re-emerge and impose significant financial and public health burden. These outbreaks are largely preventable through inexpensive and highly effective measles vaccination paired with system-level preparedness for effective containment. Since fixed response costs for any outbreak can be costly, our estimates provide improved data on how costs of measles outbreaks scale with outbreak size by isolating incremental costs associated incident new cases, as well as incident contacts, for use alongside budgetary planning and modeled risk assessments.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The Joint Impact of COVID-19 Vaccination and Non-Pharmaceutical Interventions on Infections, Hospitalizations, and Mortality: An Agent-Based Simulation 91%
- COVID-19 cases and hospitalizations averted by case investigation and contact tracing in the United States 90%
- Estimation of COVID-19 cases prevented by vaccination in California 89%
Similar papers in this journal
- COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery 93%
- Continuity of routine immunization programs in Canada during the COVID-19 pandemic 91%
- Cost-Effectiveness of Infant and Maternal RSV Immunization Strategies, in British Columbia, Canada 91%
Similar papers in this journal
- The immediate treatment outcomes and cost estimate for managing clinical measles in children admitted at Mulago Hospital: a retrospective cohort study 93%
- Cost-Effectiveness of a Pediatric Operating Room Installation in Sub-Saharan Africa 91%
- Improving the last mile delivery of vaccines through an informed push model: experiences, opportunities and costs based on an implementation study in a rural district in Uganda 91%
Similar papers in this journal
- Lives saved and hospitalizations averted by COVID-19 vaccination in New York City 89%
- Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort study 89%
- The cost of inaction to strengthen the resilience of primary health care in Latin America and the Caribbean: a modelling study 89%
Similar papers in this journal
- Cost per episode of diarrhea and respiratory syncytial virus (RSV) in 128 low- and middle-income countries: how well do disease-specific and WHO-CHOICE estimates align? 94%
- Examining Unit Costs for COVID-19 Case Management in Kenya 92%
- Impact of the COVID-19 pandemic and response on the utilisation of health services during the first wave in Kinshasa, the Democratic Republic of the Congo 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.